QTLs in Region (GRCm39)
1357460 | Vtbt4_m | vertebral trabecular bone trait 4 (mouse) | | | Not determined | | 7 | 101693381 | 135693530 | Mouse |
25314307 | Mlh1fc2_m | MLH1 foci count 2 (mouse) | | | | | 7 | 6502999 | 133501729 | Mouse |
27226781 | Tibl3_m | tibia length 3, 5 week (mouse) | | | | | 7 | 74849748 | 122199223 | Mouse |
1302032 | Alcp12_m | alcohol preference locus 12 (mouse) | | | Not determined | | 7 | 111166122 | 144995196 | Mouse |
27226778 | Femd11_m | femur midshaft diameter 11, 16 week (mouse) | | | | | 7 | 56949748 | 134001729 | Mouse |
1301781 | Capsq3_m | capsaicin sensitivity related QTL 3 (mouse) | | | Not determined | | 7 | 87143137 | 119485380 | Mouse |
11039524 | Tbbr3_m | Trypanosoma brucei brucei response 3 (mouse) | | | | | 7 | 100750722 | 134750843 | Mouse |
27226769 | Tibl12_m | tibia length 12, 10 week (mouse) | | | | | 7 | 87249208 | 126499172 | Mouse |
10043926 | Bw1n_m | body weight 1 in NSY (mouse) | | | Not determined | | 7 | 45161966 | 118693530 | Mouse |
27226765 | Tibl18_m | tibia length 18, 16 week (mouse) | | | | | 7 | 81849748 | 126499172 | Mouse |
27226763 | Feml20_m | femur length 20, 16 week (mouse) | | | | | 7 | 85049208 | 124199223 | Mouse |
1300747 | Skts2_m | skin tumor susceptibility 2 (mouse) | | | Not determined | | 7 | 112922733 | 144995196 | Mouse |
1301898 | Alcp14_m | alcohol preference locus 14 (mouse) | | | Not determined | | 7 | 111166122 | 144995196 | Mouse |
4142500 | Morq1_m | modifier of Rs1 QTL 1 (mouse) | | | Not determined | | | 80551681 | 114551791 | Mouse |
1301647 | Elpt_m | elevated leptin (mouse) | | | Not determined | | 7 | 86500186 | 120500329 | Mouse |
13208555 | Lgth10_m | body length 10 (mouse) | | | | | 7 | 51649748 | 125599172 | Mouse |
26884408 | Bzwq13_m | bi-zygomatic width QTL 13, 16 week (mouse) | | | | | 7 | 61749748 | 121399223 | Mouse |
1301937 | Skull10_m | skull morphology 10 (mouse) | | | Not determined | | 7 | 91482996 | 125483156 | Mouse |
1300528 | Ssial3_m | susceptibility to sialadenitis 3 (mouse) | | | Not determined | | 7 | 93391848 | 127392041 | Mouse |
5491192 | Mobq1_m | multigenic obesity QTL 1 (mouse) | | | Not determined | | 7 | 105250663 | 139250811 | Mouse |
1300670 | Sluc19_m | susceptibility to lung cancer 19 (mouse) | | | Not determined | | 7 | 111166122 | 144995196 | Mouse |
26884398 | Humsd6_m | humerus midshaft diameter 6, 16 week (mouse) | | | | | 7 | 78649748 | 136901729 | Mouse |
1301158 | Eae4_m | susceptibility to experimental allergic encephalomyelitis 4 (mouse) | | | Not determined | | 7 | 19147398 | 141919804 | Mouse |
10412199 | Sst2_m | susceptibility to tuberculosis 2 (mouse) | | | Not determined | | 7 | 18728794 | 119485380 | Mouse |
27226790 | Feml15_m | femur length 15, 10 week (mouse) | | | | | 7 | 87249208 | 126499172 | Mouse |
13524852 | Asrq7a_m | acoustic startle response 7a (mouse) | | | | | 7 | 105350008 | 139350008 | Mouse |
13524850 | Asrq7_m | acoustic startle response 7 (mouse) | | | | | 7 | 98394974 | 132394974 | Mouse |
1302062 | Stheal6_m | soft tissue heal 6 (mouse) | | | Not determined | | 7 | 87043932 | 121044066 | Mouse |
4141056 | Lskcn2_m | LSK cell number 2 (mouse) | | | Not determined | | | 108482996 | 118693530 | Mouse |
26884440 | Sklq4_m | skull length QTL 4, 5 week (mouse) | | | | | 7 | 65249748 | 126499172 | Mouse |
27095903 | Scvln10_m | sacral vertebrae length 2, 10 week (mouse) | | | | | 7 | 81449748 | 126499172 | Mouse |
11059562 | Lmr21b_m | leishmaniasis resistance 21b (mouse) | | | | | 7 | 110967235 | 144967336 | Mouse |
27226715 | Metcl3_m | metatarsal-calcaneal length 3, 5 week (mouse) | | | | | 7 | 67849748 | 119499223 | Mouse |
26884444 | Sklq8_m | skull length QTL 8, 10 week (mouse) | | | | | 7 | 67849748 | 124199223 | Mouse |
25823170 | Hrsq7_m | host response to SARS QTL 7, log titer (mouse) | | | | | 7 | 54819589 | 116822815 | Mouse |
1301082 | Bbaa16_m | B.burgdorferi-associated arthritis 16 (mouse) | | | Not determined | | 7 | 36280015 | 116416877 | Mouse |
10412110 | Cctq1_m | central corneal thickness QTL 1 (mouse) | | | Not determined | | 7 | 80551681 | 114551791 | Mouse |
12792978 | Fbmd3_m | femoral bone mineral density 3, females only (mouse) | | | | | 7 | 7050288 | 142367832 | Mouse |
4142444 | Femwf5_m | femur work to failure 5 (mouse) | | | Not determined | | | 112552248 | 144995196 | Mouse |
1301447 | Fembm3_m | femoral bone morphometry 3 (mouse) | | | Not determined | | 7 | 100993261 | 134993342 | Mouse |
10412104 | Tons2_m | tongue size 2 (mouse) | | | Not determined | | 7 | 99837716 | 133837716 | Mouse |
1301188 | Heal6_m | wound healing/regeneration 6 (mouse) | | | Not determined | | 7 | 87043932 | 121044066 | Mouse |
4142312 | Nilac4_m | nicotine induced locomotor activity 4 (mouse) | | | Not determined | | 7 | 102485219 | 136485380 | Mouse |
10402499 | Lmr21_m | leishmaniasis resistance 21 (mouse) | | | Not determined | | 7 | 110967235 | 144967336 | Mouse |
27226751 | Femd5_m | femur midshaft diameter 5, 10 week (mouse) | | | | | 7 | 53249748 | 143153737 | Mouse |
27095933 | Ulnl3_m | ulna length 3, 5 week (mouse) | | | | | 7 | 73149748 | 143153737 | Mouse |
1301105 | Cfld4_m | cystic fibrosis lung disease 4 (mouse) | | | Not determined | | 7 | 101693381 | 135693530 | Mouse |
1300721 | Cfbw3_m | cystic fibrosis body weight 3 (mouse) | | | Not determined | | 7 | 101693381 | 135693530 | Mouse |
27226745 | Metcl9_m | metatarsal-calcaneal length 9, 10 week (mouse) | | | | | 7 | 74849748 | 122199223 | Mouse |
27095930 | Ulnl10_m | ulna length 10, 16 week (mouse) | | | | | 7 | 80849748 | 126699172 | Mouse |
14700684 | Civq1_m | cerebral infarct volume QTL 1 (mouse) | | | | | 7 | 109707335 | 143707335 | Mouse |
27095923 | Pglq3_m | pelvic girdle length QTL 3, 5 week (mouse) | | | | | 7 | 81249748 | 124199223 | Mouse |
14700687 | Civq5_m | cerebral infarct volume QTL 5 (mouse) | | | | | 7 | 109707335 | 143707335 | Mouse |
14700688 | Civq6_m | cerebral infarct volume QTL 6 (mouse) | | | | | 7 | 109707335 | 143707335 | Mouse |
27095916 | Scvln15_m | sacral vertebrae length 2, 16 week (mouse) | | | | | 7 | 61749748 | 123699223 | Mouse |
1357664 | Nba3_m | New Zealand Black autoimmunity 3 (mouse) | | | Not determined | | 7 | 91482996 | 125483156 | Mouse |
1301478 | Eae26_m | susceptibility to experimental allergic encephalomyelitis 26 (mouse) | | | Not determined | | 7 | 98164922 | 132165010 | Mouse |
26884451 | Sklq14_m | skull length QTL 14, 16 week (mouse) | | | | | 7 | 67849748 | 124999172 | Mouse |
27095910 | Pglq13_m | pelvic girdle length QTL 13, 16 week (mouse) | | | | | 7 | 73049748 | 125699172 | Mouse |
13463473 | Hbbcq4_m | hemoglobin concentration QTL 4 (mouse) | | | | | 7 | 87043932 | 121044066 | Mouse |
27095907 | Scvln4_m | sacral vertebrae length 2, 5 week (mouse) | | | | | 7 | 69949748 | 120499223 | Mouse |
25394557 | Skmw64_m | skeletal muscle weight 64, soleus (mouse) | | | | | 7 | 108715780 | 114592736 | Mouse |
35673311 | Ari6_m | antibody response to influenza 6, day 15, IgG2b (mouse) | | | | | 7 | 108699207 | 115099235 | Mouse |